Comparative immunogenicity assessment of biosimilar natalizumab to its reference medicine: a matching immunogenicity profile
The immunogenicity profile of biosim-NTZ was confirmed to match that of ref-NTZ in healthy subjects and patients with RRMS by applying highly sensitive methods.
Authors
- Oliver von Richter (ORCID: https://orcid.org/0000-0002-5262-9922)
- Bernhard Hemmer (ORCID: https://orcid.org/0000-0001-5985-6784)
- Cyrill Hornuß (ORCID: https://orcid.org/0009-0004-9838-5646)
- Hendrik Wessels
- Josef Höfler
- Paul Chamberlain (ORCID: https://orcid.org/0000-0002-8273-140X)
- Karsten Roth (ORCID: https://orcid.org/0000-0002-9041-0227)
- Johann Poetzl
Institutions
- TUM Klinikum (DE)
- Hexal (Germany) (DE)
- SciencePharma (Poland) (PL)
- Munich Cluster for Systems Neurology (DE)
- Technical University of Munich (DE)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-12-19
- DOI
- https://doi.org/10.3389/fimmu.2024.1414304
- Citations
- 4
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.96
Funders
- Hexal AG